Lv5
878 积分 2022-03-29 加入
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
16天前
已完结
mRNA vaccines engage unconventional pathways in CD8+ T cell priming
21天前
已完结
Understanding cytokine release syndrome
28天前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
29天前
已完结
Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy
1个月前
已完结
4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T
1个月前
已完结
Evolution of differential 4‐1BB signaling in Human and Murine immune system
1个月前
已关闭
A Shared Neoantigen Vaccine Plus Immune Checkpoint Blockade Is Well-Tolerated
2个月前
已关闭
Low avidity CD8+ T cells are less exhausted than their high avidity counterparts and provide superior anti-tumor immunity
2个月前
已完结
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy
2个月前
已完结
皖公网安备34019202002308
